Stockreport

SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D. [Yahoo! Finance]

Omega Therapeutics, Inc.  (OMGA) 
PDF next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors, today announced the appointment of Roger Sawhney, M.D. [Read more]